Common Stock SEC Reporting - Delinquent
OTC Pink No Information
Contact Info
  • 511 Avenue of the Americas
  • #710
  • New York, NY 10011

Business Description

Not Available

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Mar 31, 2016 10-Q
CIK 0000943535
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 2860 - Industrial Organic Chemicals
Business Status Development Stage Company a/o
Incorporated In: DE, USA
Year of Inc. Not Available
Employees 4 a/o Mar 04, 2014
Company Officers/Contacts
Jason Lurie CFO
Company Directors
Eli Gal Levy
Chaim Lieberman
Shalom Uri Tadelis
Company Notes
  • Formerly=Advanced Plant Pharmaceuticals, Inc. until 6-2010
  • Formerly=Ventra Management, Inc. until 8-94
Service Providers
Accounting/Auditing Firm
Accell Audit & Compliance, P.A
4868 W. Gandy Blvd.
Tampa, 33611
United States

Legal Counsel
Jeffrey G. Klein P.A.
301 Yamatto Road
Suite 1240
Boca Raton, FL, 33401
United States

Investor Relations Firm
Not Available
WHEN Security Details
Share Structure
Market Value1 $49,384,174 a/o Dec 06, 2016
Authorized Shares Not Available
Outstanding Shares 89,789,407,996 a/o Nov 23, 2015
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.0007
Shareholders of Record 500 a/o Apr 16, 2013
Short Selling Data
Short Interest 30,705 (41.47%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security